You are here: Research > Current Projects > Advanced Tissue Visualization for Targeted Optical Biopsy in Cancer Surveillance
print page

Current Events

10.02.10 12:24

GSISH Second Invited Symposium 2010

GSISH member are invited to participate at the GSISH Symposium, March 20-23, 2010.

01.02.10 16:01

10th Spring School in Bioinformatics

The 10th Spring School of Bioinformatics for Molecular Biologists will be held from 14th through...

25.01.10 13:58

Job Opening

Job opening for the Project "The Role of genetic and epigenetic alterations in atopic dermatitis"

Advanced Tissue Visualization for Targeted Optical Biopsy in Cancer Surveillance

PI's: Prof. Dr. Nassir Navab, PD. Dr. med. Alexander Meining
PhD student: Selen Atasoy, Dipl. Inf.

Diagnosis at early stages of oesophageal adenocarcinoma, a highly lateral type of cancer, has the potential to prevent disease progression and increase the survival rate. The role of screening and surveillance of Barrett?s Oesophagus, being the only recognised precursor of oesophageal adenocarcinoma, is crucial for this goal. Current surveillance protocol is based on obtaining four- quadrant random biopsies during endoscopic examination. However, this protocol lacks the identification of the previous biopsy sites and thus, suffers from sampling errors due to inaccurate biopsy localisation.

The aim of the proposed Ph.D. project is to support the cancer surveillance protocol by providing an advanced tissue visualization framework for the identification and accurate targeting of previous biopsy sites. To this end, a novel anatomical/functional image registration method will be developed to combine endoscopic images with the recent functional imaging techniques such as auto-fluorescence imaging and microfonfocal microscopy. Furthermore, novel video processing techniques that allow wide-area visualization of the examined tissue will be developed. The objective of this project is to provide a highly distinctive map of the region of interest, to link the previous biopsy locations, and support the physician by targeting the same biopsy sites during surveillance examinations.